Erratum: IIImmunomodulatory effects of mixed hematopoietic chimerism: Immune tolerance in canine model of lung transplantation (American Journal of Transplantation 9:5 (1037-1047) DOI: 10.1111/j.1600-6143.2009.02619.x);Immunomodulatory effects of mixed hematopoietic chimerism: Immune tolerance in canine model of lung transplantation onses.

American Journal of Transplantation

Volumn 9, Issue 5, 2009, Pages 1037-1047

  Nash, R A ^a,b   Yunosov, M ^a   Abrams, K ^a   Hwang, B ^a   Castilla Llorente, C ^a   Chen, P ^b   Farivar, A S ^b   Georges, G E ^a,b   Hackman, R C ^a,b   Lamm, W J E ^b   Lesnikova, M ^a   Ochs, H D ^b   Randolph Habecker, J ^a   Ziegler, S F ^c   Storb, R ^a,b   Storer, B ^a,b   Madtes, D K ^a,b   Glenny, R ^b   Mulligan, M S ^b  

^a Fred Hutchinson Cancer Research Center   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c BENAROYA RESEARCH INSTITUTE   (United States)

Author keywords

Immune tolerance; Lung transplantation; Mixed chimerism

Indexed keywords

ANTIGEN; CYCLOSPORIN; INTERLEUKIN 10; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD; CD3+ T LYMPHOCYTE; CHIMERA; CONTROLLED STUDY; DOG; DONOR; GRAFT DYSFUNCTION; GRAFT RECIPIENT; GRAFT SURVIVAL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOLOGY; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; IMMUNOSUPPRESSIVE TREATMENT; LUNG GRAFT REJECTION; LUNG TRANSPLANTATION; NONHUMAN; PRIORITY JOURNAL; REDUCED INTENSITY CONDITIONING; T LYMPHOCYTE SUBPOPULATION;

EID: 65249186760     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2009.02716.x     Document Type: Erratum

References (60)

1. Ildstad ST, Sachs DH. Reconstitution with syngeneic plus allogeneic or xenogeneic bone marrow leads to specific acceptance of allografts or xenografts. Nature 1984 307 : 168 170.
2. Sykes M, Szot GL, Swenson KA, Pearson DA. Induction of high levels of allogeneic hematopoietic reconstitution and donor-specific tolerance without myelosuppressive conditioning. Nat Med 1997 3 : 783 787.
3. Kuhr CS, Allen MD, Junghanss C et al. Tolerance to vascularized kidney grafts in canine mixed hematopoietic chimeras. Transplantation 2002 73 : 1487 1493.
4. Yunusov MY, Kuhr CS, Georges GE et al. Partial donor-specific tolerance to delayed skin grafts after rejection of hematopoietic cell graft. Transplantation 2006 82 : 629 637.
5. Kuhr CS, Yunusov M, Sale G, Loretz C, Storb R. Long-term tolerance to kidney allografts in a preclinical canine model. Transplantation 2007 84 : 545 547.
6. Huang CA, Fuchimoto Y, Scheier-Dolberg R, Murphy MC, Neville DMJ, Sachs DH. Stable mixed chimerism and tolerance using a nonmyeloablative preparative regimen in a large-animal model. J Clin Invest 2000 105 : 173 181.
7. Butcher JA, Hariharan S, Adams MB, Johnson CP, Roza AM, Cohen EP. Renal transplantation for end-stage renal disease following bone marrow transplantation: A report of six cases, with and without immunosuppression. Clin Transplant 1999 13 : 330 335.
8. Fudaba Y, Spitzer TR, Shaffer J et al. Myeloma responses and tolerance following combined kidney and nonmyeloablative marrow transplantation: In vivo and in vitro analyses. Am J Transplant 2006 6 : 2121 2133.
9. Boyse EA, Lance EM, Carswell EA, Cooper S, Old LJ. Rejection of skin allografts by radiation chimaeras: Selective gene action in the specification of cell surface structure. Nature 1970 227 : 901 903.
10. Steinmuller D, Tyler JD, David CS. Cell-mediated cytotoxicity to non-MHC alloantigens on mouse epidermal cells. I. H-2 restricted reactions among strains sharing the H-2k haplotype. J Immunol 1981 126 : 1747 1753.
11. Steinmuller D. Skin allograft rejection by stable hematopoietic chimeras that accept organ allografts still is an enigma (Letter). Transplantation 2001 72 : 8 9.
12. Hettiaratchy S, Melendy E, Randolph MA et al. Tolerance to composite tissue allografts across a major histocompatibility barrier in miniature swine. Transplantation 2004 77 : 514 521.
13. Storb R, Yu C, Wagner JL et al. Stable mixed hematopoietic chimerism in DLA-identical littermate dogs given sublethal total body irradiation before and pharmacological immunosuppression after marrow transplantation. Blood 1997 89 : 3048 3054.
14. Storb R, Yu C, Zaucha JM et al. Stable mixed hematopoietic chimerism in dogs given donor antigen, CTLA4Ig, and 100 cGy total body irradiation before and pharmacologic immunosuppression after marrow transplant. Blood 1999 94 : 2523 2529.
15. Georges GE, Storb R, Thompson JD et al. Adoptive immunotherapy in canine mixed chimeras after nonmyeloablative hematopoietic cell transplantation. Blood 2000 95 : 3262 3269.
16. Trulock EP, Christie JD, Edwards LB et al. Registry of the International Society for Heart and Lung Transplantation: Twenty-fourth official adult lung and heart-lung transplantation report-2007. J Heart Lung Transplant 2007 26 : 782 795.
17. Cai J, Mao Q, Ozawa M, Terasaki PI. Lung transplantation in the United States: 1990-2005. Clinical Transplants 2005 29 35.
18. Kawai T, Cosimi AB, Spitzer TR et al. HLA-mismatched renal transplantation without maintenance immunosuppression. N Engl J Med 2008 358 : 353 361.
19. Date H, Yamane M, Toyooka S, Okazaki M, Aoe M, Sano Y. Current status and potential of living-donor lobar lung transplantation (Review). Frontiers in Bioscience 2008 13 : 1433 1439.
20. Okumura H, Ohtake S, Ontachi Y et al. Living-donor lobar lung transplantation for broncho-bronchiolitis obliterans after allogeneic hematopoietic stem cell transplantation: Does bronchiolitis obliterans recur in transplanted lungs? Int J Hematol 2007 86 : 369 373.
21. Sano Y, Date H, Nagahiro I, Aoe M, Shimizu N. Living-donor lobar lung transplantation for bronchiolitis obliterans after bone marrow transplantation. Ann Thorac Surg 2005 79 : 1051 1052.
22. Wagner JL, Burnett RC, DeRose SA, Francisco LV, Storb R, Ostrander EA. Histocompatibility testing of dog families with highly polymorphic microsatellite markers. Transplantation 1996 62 : 876 877.
23. Wagner JL, Works JD, Storb R. DLA-DRB1 and DLA-DQB1 histocompatibility typing by PCR-SSCP and sequencing (Brief Communication). Tissue Antigens 1998 52 : 397 401.
24. Ladiges WC, Storb R, Graham T, Thomas ED. Experimental techniques used to study the immune system of dogs and other large animals. In : WI Gay, JE Heavener eds.) Methods of Animal Experimentation, New York, NY : Academic Press, 1989 : 103 133.
25. Yunusov MY, Georges GE, Storb R et al. FLT3 ligand promotes engraftment of allogeneic hematopoietic stem cells without significant graft-versus-host disease. Transplantation 2003 75 : 933 940.
26. n polymorphisms to determine the origin of blood cells after allogeneic canine marrow grafting. Transplantation 1994 58 : 701 706.
27. Farivar AS, Yunusov MY, Chen P et al. Optimizing a canine survival model of orthotopic lung transplantation. Transplant Proc 2006 38 : 1638 1640.
28. Amdur MO, Mead J. Mechanics of respiration in unanesthetized guinea pigs. Am J Physiol 1958 192 : 364 368.
29. Borland C, Mist B, Zammit M, Vuylsteke A. Steady-state measurement of NO and CO lung diffusing capacity on moderate exercise in men. J Appl Physiol 2001 90 : 538 544.
30. Mink SN, Coalson JJ, Whitley L, Greville H, Jadue C. Pulmonary function tests in the detection of small airway obstruction in a canine model of bronchiolitis obliterans. Am Rev Respir Dis 1984 130 : 1125 1133.
31. Peters SG, Hyatt RE. A canine model of bronchial injury induced by nitric acid. Lung mechanics and morphologic features. Am Rev Respir Dis 1986 133 : 1049 1054.
32. Yousem SA, Berry GJ, Cagle PT et al. Revision of the 1990 working formulation for the classification of pulmonary allograft rejection: Lung Rejection Study Group. J Heart & Lung Transplantation 1996 15 (Part 1 1 15.
33. - allogeneic marrow cells. Blood 1997 90 : 1701 1708.
34. Felsburg PJ, Somberg RL, Hartnett BJ et al. Full immunologic reconstitution following nonconditioned bone marrow transplantation for canine X-linked severe combined immunodeficiency. Blood 1997 90 : 3214 3221.
35. Ochs HD, Storb R, Thomas ED et al. Immunologic reactivity in canine marrow graft recipients. J Immunol 1974 113 : 1039 1057.
36. Prussin C, Metcalfe DD. Detection of intracytoplasmic cytokine using flow cytometry and directly conjugated anti-cytokine antibodies. J Immunol Methods 1995 188 : 117 128.
37. Peeters D, Peters IR, Clercx C, Day MJ. Quantification of mRNA encoding cytokines and chemokines in nasal biopsies from dogs with sino-nasal aspergillosis. Veterinary Microbiology 2006 114 : 318 326.
38. Thellin O, Zorzi W, Lakaye B et al. Housekeeping genes as internal standards: Use and limits. J Biotechnol 1999 75 : 291 295.
39. Fuchimoto Y, Gleit ZL, Huang CA et al. Skin-specific alloantigens in miniature swine. Transplantation 2001 72 : 122 126.
40. Yunusov MY, Kuhr C, Georges GE et al. Survival of small bowel transplants in canine mixed hematopoietic chimeras: Preliminary results. Transplant Proc 2002 34 : 3366 3367.
41. Steinmuller D. The enigma of skin allograft rejection. Transplantation Reviews 1998 12 : 42 57.
42. Cortesini R, Renna-Molajoni E, Cinti P et al. Tailoring of immunosuppression in renal and liver allograft recipients displaying donor specific T-suppressor cells. Hum Immunol 2002 63 : 1010 1018.
43. Hewitt CW, Black KS, Harman JC et al. Partial tolerance in rat renal allograft recipients following multiple blood transfusions and concomitant cyclosporine. Transplantation 1990 49 : 194 198.
44. Nakao A, Nalesnik MA, Ishikawa T, Azhipa O, Demetris AJ, Murase N. Chimerism and tolerance in rat recipients of intestinal allografts from ALS-treated donors with and without adjunct naive-donor-strain bone-marrow cells. Transplantation 2003 75 : 1575 1581.
45. Sykes M. Immune tolerance: Mechanisms and application in clinical transplantation (Review). J Intern Med 2007 262 : 288 310.
46. Manilay JO, Pearson DA, Sergio JJ, Swenson KG, Sykes M. Intrathymic deletion of alloreactive T cells in mixed bone marrow chimeras prepared with a nonmyeloablative conditioning regimen. Transplantation 1998 66 : 96 102.
47. Khan A, Tomita Y, Sykes M. Thymic dependence of loss of tolerance in mixed allogeneic bone marrow chimeras after depletion of donor antigen. Peripheral mechanisms do not contribute to maintenance of tolerance. Transplantation 1996 62 : 380 387.
48. Tomita Y, Khan A, Sykes M. Role of intrathymic clonal deletion and peripheral anergy in transplantation tolerance induced by bone marrow transplantation in mice conditioned with a nonmyeloablative regimen. J Immunol 1994 153 : 1087 1098.
49. Kurtz J, Shaffer J, Lie A, Anosova N, Benichou G, Sykes M. Mechanisms of early peripheral CD4 T-cell tolerance induction by anti-CD154 monoclonal antibody and allogeneic bone marrow transplantation: Evidence for anergy and deletion but not regulatory cells. Blood 2004 103 : 4336 4343.
50. Bigenzahn S, Blaha P, Koporc Z et al. The role of non-deletional tolerance mechanisms in a murine model of mixed chimerism with costimulation blockade. Am J Transplant 2005 5 : 1237 1247.
51. Kunisaki SM, Haller GW, Fuchimoto Y, Huang CA, Sachs DH. Peripheral regulation of graft-versus-host alloreactivity in mixed chimeric miniature swine. Transplantation 2001 72 : 523 526.
52. Ahmadzadeh M, Rosenberg SA. IL-2 administration increases CD4+ CD25(hi) Foxp3 +regulatory T cells in cancer patients. Blood 2006 107 : 2409 2414.
53. Zhang H, Chua KS, Guimond M et al. Lymphopenia and interleukin-2 therapy alter homeostasis of CD4+CD25+ regulatory T cells. Nat Med 2005 11 : 1238 1243.
54. Nguyen VH, Zeiser R, Dasilva DL et al. In vivo dynamics of regulatory T-cell trafficking and survival predict effective strategies to control graft-versus-host disease following allogeneic transplantation. Blood 2007 109 : 2649 2656.
55. Ochando JC, Yopp AC, Yang Y et al. Lymph node occupancy is required for the peripheral development of alloantigen-specific Foxp3+ regulatory T cells. J Immunol 2005 174 : 6993 7005.
56. + regulatory T cells (Treg) block alloreactive host anti-donor T cells in canine mixed hematopoietic chimeras [abstract]. Blood 2005 106 (Part 1 11 867a, 3101.
57. Martin PJ, Pei J, Gooley T et al. Evaluation of a CD25-specific immunotoxin for prevention of graft-versus-host disease after unrelated marrow transplantation. Biol Blood Marrow Transplant 2004 10 : 552 560.
58. Joffre O, Gorsse N, Romagnoli P, Hudrisier D, van Meerwijk JP. Induction of antigen-specific tolerance to bone marrow allografts with CD4+CD25+ T lymphocytes. Blood 2004 103 : 4216 4221.
59. Jiang S, Camara N, Lombardi G, Lechler RI. Induction of allopeptide-specific human CD4+CD25 +regulatory T cells ex vivo. Blood 2003 102 : 2180 2186.
60. Walker MR, Carson BD, Nepom GT, Ziegler SF, Buckner JH. De novo generation of antigen-specific CD4+CD25+ regulatory T cells from human CD4+CD25- cells. Proc Natl Acad Sci USA 2005 102 : 4103 4108.